{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:23:02Z","timestamp":1791897782440,"version":"4.3.4"},"reference-count":29,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/mmr.2014.2848","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T12:45:26Z","timestamp":1415018726000},"page":"1278-1283","source":"Crossref","is-referenced-by-count":21,"title":["Identification of miR-125a-5p as a tumor suppressor of renal cell carcinoma, regulating cellular proliferation, migration and apoptosis"],"prefix":"10.3892","volume":"11","author":[{"given":"DUQUN","family":"CHEN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YIFAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENGMING","family":"SU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZUHU","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENSHUI","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUCHI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAOTING","family":"GUI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHANGQI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YONGQING","family":"LAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"key20180108001651_b1-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/CBM-2011-0176","article-title":"Renal cell carcinoma","volume":"9","author":"Cairns","year":"2010","journal-title":"Cancer Biomark"},{"key":"key20180108001651_b2-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.seminoncol.2006.06.010","article-title":"Epidemiologic aspects of renal cell carcinoma","volume":"33","author":"McLaughlin","year":"2006","journal-title":"Semin Oncol"},{"key":"key20180108001651_b3-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20180108001651_b4-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/PPO.0b013e3181867628","article-title":"Contemporary epidemiology of renal cell cancer","volume":"14","author":"Chow","year":"2008","journal-title":"Cancer J"},{"key":"key20180108001651_b5-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1102\/1470-7330.2013.9035","article-title":"Metastatic renal cell cancer","volume":"13","author":"Rasmussen","year":"2013","journal-title":"Cancer Imaging"},{"key":"key20180108001651_b6-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"9198","DOI":"10.1128\/MCB.25.21.9198-9208.2005","article-title":"Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells","volume":"25","author":"Wu","year":"2005","journal-title":"Mol Cell Biol"},{"key":"key20180108001651_b7-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2164-11-288","article-title":"Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood","volume":"11","author":"Vaz","year":"2010","journal-title":"BMC Genomics"},{"key":"key20180108001651_b8-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e69230","DOI":"10.1371\/journal.pone.0069230","article-title":"Characterization of microRNA expression profiles and the discovery of novel microRNAs involved in cancer during human embryonic development","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"key20180108001651_b9-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res"},{"key":"key20180108001651_b10-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e556","DOI":"10.1038\/cddis.2013.79","article-title":"Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced dowregulation of erbB2\/erbB3 and apoptosis in breast cancer cells","volume":"4","author":"Wang","year":"2013","journal-title":"Cell Death Dis"},{"key":"key20180108001651_b11-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jmg.2008.063123","article-title":"Germline mutation of microRNA-125a is associated with breast cancer","volume":"46","author":"Li","year":"2009","journal-title":"J Med Genet"},{"key":"key20180108001651_b12-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.3390\/ijms140611560","article-title":"MicroRNA-regulated protein-protein interaction networks and their functions in breast cancer","volume":"14","author":"Lee","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key20180108001651_b13-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e40169","DOI":"10.1371\/journal.pone.0040169","article-title":"Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF","volume":"7","author":"Bi","year":"2012","journal-title":"PLoS One"},{"key":"key20180108001651_b14-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1947601912448068","article-title":"Current progress on understanding microRNAs in glioblastoma multiforme","volume":"3","author":"Karsy","year":"2012","journal-title":"Genes Cancer"},{"key":"key20180108001651_b15-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e38298","DOI":"10.1371\/journal.pone.0038298","article-title":"Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing","volume":"7","author":"Osanto","year":"2012","journal-title":"PLoS One"},{"key":"key20180108001651_b16-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.cell.2004.12.038","article-title":"Involvement of microRNA in AU-rich element-mediated mRNA instability","volume":"120","author":"Jing","year":"2005","journal-title":"Cell"},{"key":"key20180108001651_b17-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"16636","DOI":"10.1073\/pnas.1213196109","article-title":"Complex oncogene dependence in microRNA-125a-induced myeloproliferative neoplasms","volume":"109","author":"Guo","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108001651_b18-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e31060","DOI":"10.1371\/journal.pone.0031060","article-title":"Up-regulation of microRNA-21 correlates with lower kidney cancer survival","volume":"7","author":"Zaman","year":"2012","journal-title":"PLoS One"},{"key":"key20180108001651_b19-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yexmp.2012.10.005","article-title":"Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma","volume":"94","author":"Zhao","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"key20180108001651_b20-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/gcc.21957","article-title":"Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients","volume":"51","author":"Slaby","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"key20180108001651_b21-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-10-55","article-title":"Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma","volume":"10","author":"Redova","year":"2012","journal-title":"J Transl Med"},{"key":"key20180108001651_b22-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/carcin\/bgt184","article-title":"miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma","volume":"34","author":"Khella","year":"2013","journal-title":"Carcinogenesis"},{"key":"key20180108001651_b23-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e69118","DOI":"10.1371\/journal.pone.0069118","article-title":"Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis","volume":"8","author":"Murata","year":"2013","journal-title":"PLoS One"},{"key":"key20180108001651_b24-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"e65336","DOI":"10.1371\/journal.pone.0065336","article-title":"Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression","volume":"8","author":"Coppola","year":"2013","journal-title":"PLoS One"},{"key":"key20180108001651_b25-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/1078-0432.CCR-10-2132","article-title":"MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab","volume":"17","author":"Nishida","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180108001651_b26-mmr-11-02-1278","first-page":"1477","article-title":"Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance","volume":"40","author":"Hashiguchi","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180108001651_b27-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.critrevonc.2012.08.008","article-title":"Advanced HER2-positive gastric cancer: current and future targeted therapies","volume":"85","author":"Pazo Cid","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180108001651_b28-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1358\/dot.2012.48.11.1885879","article-title":"Pertuzumab for the treatment of patients with previously untreated HER2-positive metastatic breast cancer","volume":"48","author":"Smith","year":"2012","journal-title":"Drugs Today (Barc)"},{"key":"key20180108001651_b29-mmr-11-02-1278","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1185\/03007995.2012.728132","article-title":"Pertuzumab in HER2-positive breast cancer","volume":"28","author":"Sendur","year":"2012","journal-title":"Curr Med Res Opin"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2014.2848\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T23:40:04Z","timestamp":1565998804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2014.2848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,3]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/mmr.2014.2848"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2014.2848","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,3]]}}}